Defining the Care Pathway in Patients with Psoriasis and Atopic Dermatitis


Por: Masip, M, Pagès-Puigdemont, N, López-Ferrer, A, de Paz, HD, Serra-Baldrich, E, Puig, L, Riera, P

Publicada: 1 ene 2024
Resumen:
Purpose: This study aims to map the clinical pathway for psoriasis and atopic dermatitis (AD) in a tertiary hospital to better understand patient needs and experiences, thereby suggesting improvements in patient-centered care. Methods: A mixed-method approach was utilised involving a literature review, a questionnaire for healthcare professionals (HCPs), and two focus groups (one with HCPs and the other with patients with psoriasis or AD). Ethical approvals were obtained, and informed consent was acquired from all participants. Results: Patients and HCPs identified significant delays in the pre-diagnosis phase, extending up to five years for psoriasis and three years for AD, adversely affecting the timely initiation of effective treatment. In addition, there were reported difficulties in obtaining appointments during flares, a lack of dermatologic emergencies, a need to increase human resources and physical space, and a need for telematic consultations for urgent cases. Discrepancies between HCPs' perceptions and patients' experiences highlighted unmet needs, particularly in primary care settings and emergency departments. Several strengths were also identified, including satisfactory experience in dermatology, the hospital's high level of specialisation in the management of complex patients, optimal communication between services, consideration of patient preferences, and proper advice on hospital pharmacy care and administration support of treatment and adherence monitoring. Conclusion: The findings underscore the necessity for interventions to reduce wait times and improve treatment immediacy and effectiveness post-diagnosis. The insights from this study can direct enhancements in patient management and satisfaction for individuals with psoriasis and AD.

Filiaciones:
Masip, M:
 Hosp Santa Creu & Sant Pau, Pharm Serv, St Quinti 81, Barcelona 08041, Spain

 Inst Recerca St Pau IR St Pau, Barcelona, Spain

Pagès-Puigdemont, N:
 Hosp Santa Creu & Sant Pau, Pharm Serv, St Quinti 81, Barcelona 08041, Spain

 Inst Recerca St Pau IR St Pau, Barcelona, Spain

López-Ferrer, A:
 Inst Recerca St Pau IR St Pau, Barcelona, Spain

 Hosp Santa Creu & Sant Pau, Dermatol Dept, Barcelona, Spain

de Paz, HD:
 Outcomes10, ProductLife Grp Co, Castellon De La Plana, Spain

Serra-Baldrich, E:
 Inst Recerca St Pau IR St Pau, Barcelona, Spain

 Hosp Santa Creu & Sant Pau, Dermatol Dept, Barcelona, Spain

Puig, L:
 Inst Recerca St Pau IR St Pau, Barcelona, Spain

 Hosp Santa Creu & Sant Pau, Dermatol Dept, Barcelona, Spain

Riera, P:
 Hosp Santa Creu & Sant Pau, Pharm Serv, St Quinti 81, Barcelona 08041, Spain

 Inst Recerca St Pau IR St Pau, Barcelona, Spain
ISSN: 1177889X
Editorial
DOVE MEDICAL PRESS LTD, PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND, Reino Unido
Tipo de documento: Article
Volumen: 18 Número:
Páginas: 2325-2335
WOS Id: 001357949000001
ID de PubMed: 39574936
imagen gold

MÉTRICAS